Thanks for your view on this. Worth noting is a couple of counter points here that you are over-looking:
'I simply don't think any Accelerator type funding requirement is needed in the short-term should they decide to go that way. The next development that would possibly fit into this requirement imo is the Bodyguard'
I don't believe this to be so. In the recent Investor Conference Call it was made crystal clear that the first Accelerator program will in fact be in relation to Skincare from the Singapore base Accelerator and not the Chicago one which should be for BodyGuard:
Jeff: Discussed at a meeting with an accelerator in Singapore last week, which is closely aligned with P&G. Not related to BodyGuard but in the skin care market.
Accelerators: Accelerator - we met with one in SG last week... closely aligned with P&G. Terrific opportunity we will have a formal arrangement with that accelerator... not BG but another product
Another accelerator based in Chicago, interested in BG.. want to do consumer testing themselves. Haven't reached any commercial discussion with them. SG is more advanced.
'In the meantime they made a concerted effort to tell us that expenses are reducing, and in light of the cash on hand'
They also made a concerted effort to let us know the following:
'Spent quite a fair bit on patents
Patents are increasing in number but also increasing in costs
Quite expensive for company
OBJ Price at posting:
3.5¢ Sentiment: Buy Disclosure: Held